Change in global burden of depressive and anxiety disorders due to pandemic: Insight from GBD 2021
Journal of Affective Disorders · 2025
DOI: 10.1016/j.jad.2025.119817 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Affective Disorders, 2025. Verfasst von Hongxuan Fan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing 102218, China; School of Cli…. Hauptthemen laut MEDLINE: COVID-19, Anxiety Disorders, Major Depressive Disorder, Global Burden of Disease. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Beijing Municipal Health Commission.
Abstract (Originalsprache)
BACKGROUND: Few studies have focused on trends in changes in major depressive disorder (MDD) and anxiety disorder (AD) during COVID-19 pandemic, especially among different sociodemographic index (SDI) regions. METHODS: The Global Burden of Disease (GBD) Study 2021 was utilized to describe the temporal trends in age-standardized incidence rates (ASIRs) of MDD and AD from 1990 to 2021 and to compare the ASIRs of COVID-19, MDD and AD for different sexes, age groups and SDI regions between 2019 and 2021. OUTCOMES: Globally, the burdens of MDD and AD significantly increased from 2019 to 2021. In 2021, the global incidence of MDD was estimated at 341.1 million cases, with an ASIR of 4135.1 per 100,000 people, while AD accounted for 53.9 million cases, corresponding to an ASIR of 678.3 per 100,000 people. Surprisingly, high-SDI regions, which appeared to be least affected by the pandemic, presented the most pronounced increase in the ASIRs of patients with MDD, especially women. Interestingly, high-income North America, Western Europe and the high-income Asia-Pacific region, which are less severely affected by the pandemic, presented significant increases in the percentages of patients with MDD and AD. INTERPRETATION: Our study revealed that the pandemic had a profound impact on the global burden of depressive and anxiety disorders, which dramatically increased in just two years. Notably, high-SDI regions, which are less affected by pandemics, had the greatest increases in MDD and AD incidence, especially among young women in high-SDI regions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing 102218, China; School of Clinical Medicine, Tsinghua University, Beijing 100084, China.
- Department of Cardiology, The Second Hospital of Shanxi Medical University, China.
- Department of Cardiology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing 102218, China. Electronic address: zhouboda@tsinghua.edu.cn.
Förderung
- National Natural Science Foundation of China
- Beijing Municipal Health Commission
Zitieren
APA
Fan, H., Yang, Y., Li, J., Huang, Z., & Zhou, B. (2025). Change in global burden of depressive and anxiety disorders due to pandemic: Insight from GBD 2021. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2025.119817
Vancouver
Fan H, Yang Y, Li J, Huang Z, Zhou B. Change in global burden of depressive and anxiety disorders due to pandemic: Insight from GBD 2021. Journal of Affective Disorders. 2025. doi:10.1016/j.jad.2025.119817
BibTeX
@article{Fan2025,
author = {Fan, Hongxuan and Yang, Yafen and Li, Jiahui and Huang, Zhuolin and Zhou, Boda},
title = {Change in global burden of depressive and anxiety disorders due to pandemic: Insight from GBD 2021},
journal = {Journal of Affective Disorders},
year = {2025},
doi = {10.1016/j.jad.2025.119817}
}
EUVIMED